Trial intelligence / Profile preview

Acetyl L-carnitine for Prevention of Neuropathy in HIV Patients

NCT00225160Phase 2Unknown

Sponsor
Royal Free London NHS Foundation Trust
Start
Nov 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetyl-l-carnitine in distal symmetric polyneuropathy (DSP), sponsored by Royal Free London NHS Foundation Trust. Status: unknown.

02

Drugs

acetyl-l-carnitine
03

Conditions

distal symmetric polyneuropathy (DSP)

Beyond the preview

Go deeper on NCT00225160.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00225160.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call